Women at greater risk of CV disease around menopause: SWAN study
PITTSBURGH- Scientists at the University of Pittsburgh Graduate School of Public Health have found that a marker for heart disease risk considerably worsens as women transition through menopause.This is the finding of a new analysis from the largest and longest running study of women's health in midlife, the Study of Women's Health Across the Nation (SWAN). The results have been published in...
PITTSBURGH- Scientists at the University of Pittsburgh Graduate School of Public Health have found that a marker for heart disease risk considerably worsens as women transition through menopause.This is the finding of a new analysis from the largest and longest running study of women's health in midlife, the Study of Women's Health Across the Nation (SWAN).
The results have been published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology.
Black women experience this accelerated decline earlier in menopause than their white counterparts.Researchers stated that the findings add to growing evidence that menopause is a critical time for changes in cardiovascular health and underscore the importance of women and their doctors focusing on heart health during the menopausal transition.
"Midlife is not just a period where women have hot flashes and experience other menopausal symptoms," said senior author Samar R. El Khoudary, Ph.D., M.P.H., associate professor of epidemiology at Pitt Public Health. "It's a time when their cardiovascular disease risk is increasing as we see significant changes in multiple clinical measures of their physical health."
El Khoudary and her team used a subset of data from SWAN Heart, an ancillary study that enrolled women from Pittsburgh and Chicago between 2001 and 2003 and included two examinations of early markers of cardiovascular health over time. Ultimately, 339 women were included in this study, 36% black and the rest white.
The study focused on how arterial stiffness changes as women transition through menopause. Arterial stiffness refers to the elasticity of arteries and is measured by looking at how fast blood flows through arteries. Stiffer arteries can lead to dysfunction in how well the heart pumps and moves blood, and damage to the heart, kidneys and other organs.
The researchers tracked the women through SWAN for up to 12.5 years, or until they reached menopause, allowing them to confidently anchor the arterial stiffness measure to the menopausal transition.
On average, as women went through menopause, their arterial stiffness increased by about 0.9% up to one year before their last menstrual period to about 7.5% within one year before and after their last period, a considerable acceleration. The black women in the study experienced greater increases in arterial stiffness earlier in the transition than white women, more than a year before menopause. The findings held after adjusting for numerous factors that could affect heart health, including waist circumference, blood pressure, lipids, smoking status, physical activity levels and financial stress.
"SWAN is a unique source of data on changes in women's health over several decades, and this is the latest in a long line of research by our team and others that indicates the menopausal transition is a very important time for heart health," said lead author Saad Samargandy, M.P.H., a Ph.D. student at Pitt Public Health. "While there are limitations to our study, including that a sizeable minority of the women had their arterial stiffness measured at only one time point, we were still able to see that major changes to cardiovascular disease risk happen around menopause."
This study follows several others that link the menopausal transition to the accumulation of heart fat, changes in cholesterol, inflammation and coronary artery calcification, among other heart disease risk factors.
"Our study is not able to tell us why we're seeing these changes during the menopausal transition," El Khoudary said. "But we speculate that the dramatic hormonal changes accompanying menopause might play a role by increasing inflammation and affecting vascular fat deposition, a hypothesis that we would like to test in future studies."
Clinical trials will be needed to test if lifestyle interventions, such as changes to diet or physical activity; medications, such as statins or hormone replacement therapy; or even increased screening and tracking of measures of heart health could be beneficial as women go through menopause, she said.
"But we can say, right now, that women should be made aware that their cardiovascular health is likely to worsen as they go through menopause," El Khoudary said. "Therefore, frequent monitoring of cardiovascular risk factors may be prudent, particularly in black women who are at even greater risk earlier in the menopausal transition."
For further reference log on to:
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Before Joining Medical Dialogues, he has served at important positions in the medical industry in India including as the Hony. Secretary of the Delhi Medical Association as well as the chairman of Anti-Quackery Committee in Delhi and worked with other Medical Councils in India. Email: email@example.com. Contact no. 011-43720751